Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.

Psychiatry J

Depression Clinical & Research Program, Massachusetts General Hospital, Boston, MA 02114, USA ; Department of Psychiatry, The Mount Sinai Hospital, New York, NY 10029, USA.

Published: September 2015

Transcranial near-infrared radiation (NIR) is an innovative treatment for major depressive disorder (MDD), but clinical evidence for its efficacy is limited. Our objective was to investigate the tolerability and efficacy of NIR in patients with MDD. We conducted a proof of concept, prospective, double-blind, randomized study of 6 sessions of NIR versus sham treatment for patients with MDD, using a crossover design. Four patients with MDD with mean age 47 ± 14 (SD) years (1 woman and 3 men) were exposed to irradiance of 700 mW/cm(2) and a fluence of 84 J/cm(2) for a total NIR energy of 2.40 kJ delivered per session for 6 sessions. Baseline mean HAM-D17 scores decreased from 19.8 ± 4.4 (SD) to 13 ± 5.35 (SD) after treatment (t = 7.905; df = 3; P = 0.004). Patients tolerated the treatment well without any serious adverse events. These findings confirm and extend the preliminary data on NIR as a novel intervention for patients with MDD, but further clinical trials are needed to better understand the efficacy of this new treatment. This trial is registered with ClinicalTrials.gov NCT01538199.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556873PMC
http://dx.doi.org/10.1155/2015/352979DOI Listing

Publication Analysis

Top Keywords

patients mdd
16
major depressive
8
depressive disorder
8
proof concept
8
mdd clinical
8
nir
5
treatment
5
mdd
5
patients
5
near-infrared transcranial
4

Similar Publications

Major depressive disorder (MDD) is associated with substantial morbidity and mortality, yet its diagnosis and treatment rates remain low due to its diverse and often overlapping clinical manifestations. In this context, electroencephalography (EEG) has gained attention as a potential objective tool for diagnosing depression. This study aimed to evaluate the effectiveness of EEG in identifying MDD by analyzing 140 EEG recordings from patients diagnosed with depression and healthy volunteers.

View Article and Find Full Text PDF

Background: Electroconvulsive therapy (ECT) is an effective treatment for treatment-resistant depression (TRD). There are limited data on the improvement of anxiety symptoms in patients receiving ECT for TRD.

Objective: The aim of the study was to examine the extent to which anxiety symptom severity improves, relative to improvements in depressive symptoms, in TRD patients receiving an acute course of ECT.

View Article and Find Full Text PDF

Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention.

Circ Cardiovasc Interv

January 2025

Division of Cardiology, Department of Medicine, University of Washington Medical Center, Seattle (E.J.S., T. Salahuddin, J.A.D.).

Background: Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). However, IVI is underutilized and is not yet established as a performance measure for quality PCI.

Methods: We examined temporal trends of IVI use for all PCIs performed at Veterans Affairs hospitals in the United States from 2010 to 2022 using retrospective observational cohorts.

View Article and Find Full Text PDF

Background: Stress is a significant risk factor for psychiatric disorders such as major depressive disorder (MDD) and panic disorder (PD). This highlights the need for advanced stress-monitoring technologies to improve treatment. Stress affects the autonomic nervous system, which can be evaluated via heart rate variability (HRV).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!